Advertisement Stepan Specialty takes over Lipid Nutrition product lines - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Stepan Specialty takes over Lipid Nutrition product lines

Stepan Specialty Products, a subsidiary of Stepan, has acquired Lipid Nutrition's Clarinol, Marinol and Pinnothin product lines.

Stepan said the acquired product lines will be integrated into Stepan’s Food and Health Specialties business, which will be renamed Stepan Lipid Nutrition.

Lipid Nutrition claims Clarinol conjugated linoleic acid reduces body fat and increases lean muscle mass.

It was approved by the US Food and Drug Administration as GRAS for use in certain food products in 2008.

Marinol concentrated Omega-3 triglycerides are used in clinical and infant nutritional products to promote cardiovascular and neurological health.

Pinnothin, derived from pine nuts, functions as an appetite suppressant.

Stepan president and CEO Quinn Stepan said the Lipid Nutrition product lines combined with their Neobee Medium ChainTriglycerides products provides them with a portfolio of nutritional fats for the food, supplement and nutrition industries.

The acquired products will be manufactured at Stepan’s Maywood, New Jersey plant as well as at existing outside contract manufacturers for sale on a global basis.